Search results
Results from the WOW.Com Content Network
Several toxicology experts said the mushrooms listed as ingredients, such as lion’s mane or ashwagandha, don’t produce the potent effects that the company touts, like relaxation or euphoria.
At UVA, researchers analyzing the gummies found caffeine, ephedrine, and kratom—an herb that produces opioid-like effects and carries the risk of addiction—along with the psilocybin, which ...
The company said that the products contain muscimol, a chemical found in some mushrooms, that "could be a potential cause of symptoms consistent with those observed in persons who became ill after ...
Muscimol (also known as agarin or pantherine) is one of the principal psychoactive constituents of Amanita muscaria and related species of mushroom. Muscimol is a potent and selective orthosteric agonist for the GABA A receptor [3] and displays sedative-hypnotic, depressant and hallucinogenic [citation needed] psychoactivity.
The effects are similar to the experience following consumption of LSD, although milder. [70] Common side effects of mushroom ingestion include pupil dilation, increased heart rate, unpleasant mood, and overresponsive reflexes. As is typical of the symptoms associated with psilocybin mushroom ingestion, "the effect on mood in particular is ...
Side effects of thiocolchicoside can include nausea, allergy and vasovagal reactions. [15] Liver injury, pancreatitis, seizures, blood cell disorders, severe cutaneous disorders, rhabdomyolysis, and reproductive disorders have all been recorded in the French and European pharmacovigilance databases and in the periodic updates that the companies concerned submit to regulatory agencies.
Like other dietary supplements and male enhancement pills, over-the-counter ED products like gummies often fail to outperform placebos in research and may be unsafe if you use other types of ...
Psilacetin, also known as O-acetylpsilocin or as 4-acetoxy-N,N-dimethyltryptamine (4-acetoxy-DMT or 4-AcO-DMT), is a semi-synthetic serotonergic psychedelic drug that has been suggested by David Nichols to be a potentially useful alternative to psilocybin for pharmacological studies, as they are both believed to be prodrugs of psilocin.